TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

NHS National Generic Pharmaceuticals - Lenalidomide

Pharmaceutical products
UK
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS England: "NHS National Generic Pharmaceuticals - Lenalidomide". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityNHS EnglandScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: NHS England
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for NHS England. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
39.4Bids / Report
5.2% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 312 active published awards; 310 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityNHS England
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSFramework
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published30 Sept 2022, 11:47 BST
Last source update30 Sept 2022, 11:47 BST
Recurring procurementNot published
ClassificationPharmaceutical products
Delivery area
UK
OCIDocds-h6vhtk-02ee98
What is being bought
NHS National Generic Pharmaceuticals- Lenalidomide<br/>Offer reference number: CM/PHG/21/5638<br/>Period of framework agreement: 01/09/2022 to 31/08/2023 (12 months) with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 48 months.<br/>Potential periods of call-offs under the framework agreement:<br/>Lenalidomide:<br/>ALL REGIONS: 01/09/2022 to 31/08/2023 (12 months)
What changed
From the official release history
  1. tender value changed
    30 Sept 2022, 11:47 BST
  2. Status changed to complete
    30 Sept 2022, 11:47 BST
  3. Official notice release published
    30 Sept 2022, 11:47 BST
  4. Submission deadline changed to published date
    30 Sept 2022, 11:47 BST
  5. Published value updated to £70,000,000
    28 Jun 2022, 10:04 BST
  6. Status changed to active
    28 Jun 2022, 10:04 BST
  7. Official notice release published
    28 Jun 2022, 10:04 BST
  8. Submission deadline changed to 18 Jul 2022, 13:00 BST
    28 Jun 2022, 10:04 BST
  9. Buyer information updated
    28 Jun 2022, 10:04 BST
  10. Published value updated to £116,000,000
    21 Oct 2021, 14:57 BST
  11. Status changed to planned
    21 Oct 2021, 14:57 BST
  12. Official notice release published
    21 Oct 2021, 14:57 BST
  13. Buyer information updated
    21 Oct 2021, 14:57 BST
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    cancelled
    Published valueNot published
    Invitation to offer for NHS National Generic Pharmaceuticals - Lenalidomide<br/>Offer reference number: CM/PHG/21/5638<br/>Period of framework agreement: 01/09/2022 to 31/08/2023 (12 months) with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 48 months.<br/><br/>Potential periods of call-offs under the framework agreement:<br/><br/>Lenalidomide:<br/>ALL REGIONS: 01/09/2022 to 31/08/2023 (12 months) Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    30 Sept 2022, 11:47 BST
  2. Award active
    Not published · Not published
  3. Award active
    Not published · Not published
  4. Award active
    Not published · Not published
  5. Award active
    Not published · Not published
  6. Award active
    Not published · Not published
  7. Award active
    Not published · Not published
  8. Award active
    Not published · Not published
  9. Award active
    Not published · Not published
  10. Award active
    Not published · Not published
  11. Award active
    Not published · Not published
  12. Award active
    Not published · Not published
  13. Award active
    Not published · Not published
  14. Award active
    Not published · Not published
  15. Award active
    Not published · Not published
  16. Contract active
    Signed 31 Aug 2022, 00:00 BST · £1
  17. Contract active
    Signed 31 Aug 2022, 00:00 BST · £1
  18. Contract active
    Signed 31 Aug 2022, 00:00 BST · £1
  19. Contract active
    Signed 31 Aug 2022, 00:00 BST · £1
  20. Contract active
    Signed 31 Aug 2022, 00:00 BST · £1
  21. Contract active
    Signed 31 Aug 2022, 00:00 BST · £1
  22. Contract active
    Signed 31 Aug 2022, 00:00 BST · £1
  23. Contract active
    Signed 31 Aug 2022, 00:00 BST · £1
  24. Contract active
    Signed 31 Aug 2022, 00:00 BST · £1
  25. Contract active
    Signed 31 Aug 2022, 00:00 BST · £1
  26. Contract active
    Signed 31 Aug 2022, 00:00 BST · £1
  27. Contract active
    Signed 31 Aug 2022, 00:00 BST · £1
  28. Contract active
    Signed 31 Aug 2022, 00:00 BST · £1
  29. Contract active
    Signed 31 Aug 2022, 00:00 BST · £1
Commercial outcome and competition
Awards
Mercury Pharmaceuticals Limited
Not published · Not published · active
Thornton and Ross Ltd
Not published · Not published · active
Piramal Critical care Limited
Not published · Not published · active
Ranbaxy UK
Not published · Not published · active
Mylan
Not published · Not published · active
Zentiva Pharma UK Ltd
Not published · Not published · active
Accord-UK Ltd
Not published · Not published · active
Morningside Pharmaeuticals
Not published · Not published · active
Amarox Limited
Not published · Not published · active
Teva UK Limited
Not published · Not published · active
Bristol Myers Squibb
Not published · Not published · active
Glenmark Pharmaceuticals Europe Limited
Not published · Not published · active
Sandoz Ltd
Not published · Not published · active
Wockhardt UK Limited
Not published · Not published · active
Contracts
Contract
£1 · signed 31 Aug 2022, 00:00 BST · active
Contract
£1 · signed 31 Aug 2022, 00:00 BST · active
Contract
£1 · signed 31 Aug 2022, 00:00 BST · active
Contract
£1 · signed 31 Aug 2022, 00:00 BST · active
Contract
£1 · signed 31 Aug 2022, 00:00 BST · active
Contract
£1 · signed 31 Aug 2022, 00:00 BST · active
Contract
£1 · signed 31 Aug 2022, 00:00 BST · active
Contract
£1 · signed 31 Aug 2022, 00:00 BST · active
Contract
£1 · signed 31 Aug 2022, 00:00 BST · active
Contract
£1 · signed 31 Aug 2022, 00:00 BST · active
Contract
£1 · signed 31 Aug 2022, 00:00 BST · active
Contract
£1 · signed 31 Aug 2022, 00:00 BST · active
Contract
£1 · signed 31 Aug 2022, 00:00 BST · active
Contract
£1 · signed 31 Aug 2022, 00:00 BST · active
Bid statistics
bids: 16 (lot 1)
bids: 16 (lot 1)
bids: 16 (lot 1)
bids: 16 (lot 1)
bids: 16 (lot 1)
bids: 16 (lot 1)
bids: 16 (lot 1)
bids: 16 (lot 1)
bids: 16 (lot 1)
bids: 16 (lot 1)
bids: 16 (lot 1)
bids: 16 (lot 1)
bids: 16 (lot 1)
bids: 16 (lot 1)
electronicBids: 16 (lot 1)
electronicBids: 16 (lot 1)
electronicBids: 16 (lot 1)
electronicBids: 16 (lot 1)
electronicBids: 16 (lot 1)
electronicBids: 16 (lot 1)
electronicBids: 16 (lot 1)
electronicBids: 16 (lot 1)
electronicBids: 16 (lot 1)
electronicBids: 16 (lot 1)
electronicBids: 16 (lot 1)
electronicBids: 16 (lot 1)
electronicBids: 16 (lot 1)
electronicBids: 16 (lot 1)
foreignBidsFromEU: 0 (lot 1)
foreignBidsFromEU: 0 (lot 1)
foreignBidsFromEU: 0 (lot 1)
foreignBidsFromEU: 0 (lot 1)
foreignBidsFromEU: 0 (lot 1)
foreignBidsFromEU: 0 (lot 1)
foreignBidsFromEU: 0 (lot 1)
foreignBidsFromEU: 0 (lot 1)
foreignBidsFromEU: 0 (lot 1)
foreignBidsFromEU: 0 (lot 1)
foreignBidsFromEU: 0 (lot 1)
foreignBidsFromEU: 0 (lot 1)
foreignBidsFromEU: 0 (lot 1)
foreignBidsFromEU: 0 (lot 1)
foreignBidsFromNonEU: 16 (lot 1)
foreignBidsFromNonEU: 16 (lot 1)
foreignBidsFromNonEU: 16 (lot 1)
foreignBidsFromNonEU: 16 (lot 1)
foreignBidsFromNonEU: 16 (lot 1)
foreignBidsFromNonEU: 16 (lot 1)
foreignBidsFromNonEU: 16 (lot 1)
foreignBidsFromNonEU: 16 (lot 1)
foreignBidsFromNonEU: 16 (lot 1)
foreignBidsFromNonEU: 16 (lot 1)
foreignBidsFromNonEU: 16 (lot 1)
foreignBidsFromNonEU: 16 (lot 1)
foreignBidsFromNonEU: 16 (lot 1)
foreignBidsFromNonEU: 16 (lot 1)
smeBids: 7 (lot 1)
smeBids: 7 (lot 1)
smeBids: 7 (lot 1)
smeBids: 7 (lot 1)
smeBids: 7 (lot 1)
smeBids: 7 (lot 1)
smeBids: 7 (lot 1)
smeBids: 7 (lot 1)
smeBids: 7 (lot 1)
smeBids: 7 (lot 1)
smeBids: 7 (lot 1)
smeBids: 7 (lot 1)
smeBids: 7 (lot 1)
smeBids: 7 (lot 1)
Buyer and organisations in this procedure

NHS England

Contracting authority GB-FTS-3717
View buyer profile

  • NHS England
    buyer
    centralPurchasingBody

    Quarry House, Leeds, UKE, LS2 7UE
    lynne.tierney@nhs.net

  • Accord-UK Ltd
    supplier

    Whiddon Valley, Barnstaple, UK, EX32 8NS

  • Amarox Limited
    supplier

    Congress House, 3rd Floor, 14 Lyon Road, Harrow, UK, HA1 2EN

  • Bristol Myers Squibb
    supplier

    BMS House, Sanderson Road,, Uxbridge, UK, UB8 1DH

  • Glenmark Pharmaceuticals Europe Limited
    supplier

    Building 2, Croxley Park,, Watford, UK, WD18 8YA

  • Mercury Pharmaceuticals Limited
    supplier

    Capital House, 1st Floor, 85 King William Street, London, UK, EC4N 7B

  • Morningside Pharmaeuticals
    supplier

    5 Pavilion Way,, Loughborough, UK, LE11 5GW

  • Mylan
    supplier

    Building 4, Trident Place, Mosquito Way,, Hatfield, UK, AL10 9UL

  • Piramal Critical care Limited
    supplier

    Suite 4 Heathrow Boulevard East Wing 280 Bath Road, West Drayton, UK, UB7 0DQ

  • Ranbaxy UK
    supplier

    6-9 The Square, Stockley Park, Uxbridge, UK, UB11 1FW

  • Sandoz Ltd
    supplier

    Park View, Riverside Way, Watchmoor Park,, Camberley, UK, GU15 3YL

  • Teva UK Limited
    supplier

    Ridings Point, Whistler Drive,, Castleford, UK, WF10 5HX

  • The High Court
    reviewBody

    Strand, London, WC2A 2LL
    generaloffice@administrativecourtoffice.justice.gov.uk

  • Thornton and Ross Ltd
    supplier

    Linthwaite Laboratories, Manchester Road, Linthwaite, Huddersfield, UK, HD7 5QH

  • Wockhardt UK Limited
    supplier

    Ash Road North, Wrexham Industrial Estate, Wrexham, UK, LL13 9UF

  • Zentiva Pharma UK Ltd
    supplier

    Office 112, Austen House, Station View, Guildford, UK, GU1 4AR
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published